Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Summary

Almost all antipsychotics can induce dyslipidemia, but no treatment has been established. Vildagliptin can improve lipid levels in obese patients. The investigators conducted a randomized, placebo-controlled study to test the efficacy of vildagliptin for antipsychotic-induced dyslipidemia.

Timeline

Start

2021-02-16

Primary completion

2025-12-31

Completion

2025-12-31

Drugs

Indications